COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk (RoBaCO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03113994
Recruitment Status : Recruiting
First Posted : April 14, 2017
Last Update Posted : October 12, 2020
The Craig H. Neilsen Foundation
Toronto Rehabilitation Institute
University Health Network, Toronto
University of Miami
Rick Hansen Institute
Information provided by (Responsible Party):
Dr. B. Catharine. Craven, Toronto Rehabilitation Institute

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2022
Estimated Study Completion Date : December 2022